Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An RF network and a dual-tuned surface coil are described for obtaining proton-decoupled, NOE enhanced 19F spectra from a whole body clinical imager operating at 1.5 Tesla. The network removes 19F frequency noise from the decoupler transmitter and prevents preamplifier saturation from high- level decoupling signals. Proton decoupling of 19F spectra was optimized using a sample of urine containing 5-fluorouracil (5-FU) and its catabolite fluoro-β-alanine (FBAL). Proton-decoupled 19F spectroscopy in vivo is demonstrated by obtaining both nonlocalized spectra and spectra localized with three-dimensional chemical shift imaging from the liver of patients undergoing 5-FU chemotherapy.

Cite

CITATION STYLE

APA

Murphy-Boesch, J., Li, C. W., He, L., Padavic-Shaller, K. A., Negendank, W., & Brown, T. R. (1997). Proton-decoupled 19F spectroscopy of 5-FU catabolites in human liver. Magnetic Resonance in Medicine, 37(3), 321–326. https://doi.org/10.1002/mrm.1910370302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free